GranuFlo® and NaturaLyte® Recall
Dialysis Products May Cause Heart Attack And Stroke. Fresenius Medical Care, the largest operator of hemodialysis clinics in the U.S., as well as the leading supplier of dialysis machines and disposable products and supplies, is under investigation for failing to inform customers of a potentially deadly heart risk connected … [Read more...] about GranuFlo® and NaturaLyte® Recall
Fresenius GranuFlo and NaturaLyte Whistleblower
GranuFlo False Claims Lawsuit. The whistleblower attorneys at the national law firm Parker Waichman LLP are investigating potential whistleblower lawsuits against Fresenius Medical Care involving its GranuFlo® and NaturaLyte® dialysis products. If a former or current Fresenius employee successfully pursues a Fresenius … [Read more...] about Fresenius GranuFlo and NaturaLyte Whistleblower
Fresenius Proposes $250M Settlement
Risk of Dialysis Drug Fresenius has agreed to pay $250 million to settle lawsuits alleging it hid information involving the risks of its dialysis drugs, GranuFlo and NaturaLyte. Dialysis is a treatment that essentially acts as an artificial kidney. Patients who have renal failure undergo dialysis in order to remove wastes from the … [Read more...] about Fresenius Proposes $250M Settlement
GranuFlo and NaturaLyte Dialysis Product Lawsuits
GranuFlo and NaturaLyte Dialysis Product Lawsuits Centralized. On March 29, 2013, the United States Judicial Panel on Multidistrict Litigation moved to consolidate lawsuits alleging injuries or death from GranuFlo and NaturaLyte dialysis products into a multidistrict litigation (MDL No. 2428) to more effectively deal with common … [Read more...] about GranuFlo and NaturaLyte Dialysis Product Lawsuits
